With reference to the disclosure made by Indorama Ventures Public Company Limited (“IVL”) on July 19th, 2018 regarding the acquisition of 74% of the share capital of Medco Plast for Packing and Packaging

without warning statements or warning practices are unclear. The SEC is therefore conducting this public hearing on a proposed amendment to the relevant regulations to establish a clear standard of warning

was completed. The company?s financial statements, accordingly, contains unclear item as to reasonableness of the said transaction which may affect the benefit of securities holders and investment

.”  However, the information disclosed by CPAXT may be incomplete or unclear regarding the joint investment in the said project. This could potentially impact the rights and benefits of the shareholders

subject to temporary trading suspension. In addition, the company must proceed to have new operating business to meet the SET regulations within 12 months while its business plan remains unclear

a registration statement previously filed by this applicant. However, the SEC found the same deficiencies on issues such as related party transactions and unclear separation of businesses the

Samaha for the acquisition of 74% of the share capital of Medco Plast for Packing and Packaging Systems S.A.E., Egypt (“MEDCO”). MEDCO is the largest PET convertor in Egypt with market share of approx. 25

บริษัท อินโดรามา เวนเจอร์ส จ ากดั (มหาชน) (“บริษัท”) ได้มีการเปิดเผยสารสนเทศ เมื่อวนัท่ี 19 กรกฏาคม 2561 เก่ียวกับการเข้าซือ้กิจการในอตัราร้อยละ 74 ของทุนเรือนหุ้นของบริษัท Medco Plast for Packing and

company directors and the unclear information regarding the invitation to the Board of Directors meeting, the SEC has therefore instructed JKN and persons involved to give additional clarification and

deposit made for a due diligence on A Day amounting to 120 million baht. The SEC viewed that POLAR ' s statement on the above issues is unclear. In addition, POLAR is currently unable to submit its